Available at Amazon, Barnes and Noble, Christian Book and fine booksellers everywhere
Thanks to Ministry-To-Children!
“The most complete special needs ministry resource I’ve ever come across.”
- 2020 has been tough on first responders: a pandemic, wildfires in many places, hurricanes and civil unrest.… twitter.com/i/web/status/1… 29 minutes ago
- At 12pm EDT. Register or see livestream on Facebook. Pastors overwhelmed with 2020 needs, can find it difficult to… twitter.com/i/web/status/1… 3 hours ago
- Must read from @BarnaGroup: "The Church is pretty good at [handling] acute situations, even highly acute...if someo… twitter.com/i/web/status/1… 15 hours ago
- #Fear #trust #Jesus #Bible #specialneeds #mentalhealth #emotionalhealth #OnlinePastorsRetreat #Pastor #church… twitter.com/i/web/status/1… 20 hours ago
- #internationalweekofthedeaf. Special needs minister: what are some things your team can do to ensure inclusion of s… twitter.com/i/web/status/1… 1 day ago
Honored to be in Sharecare Now’s Top Ten online influencers in children’s mental health!
Tag Archives: FDA
Patients with depression were eleven times more likely to experience significant benefit from antidepressant medication than to experience medication-related suicidal thinking or behavior, patients with OCD were thirty-four times more likely to experience benefit and patients with non-OCD anxiety were thirty-six times more likely to experience benefit. Continue reading
Few topics in child and adolescent mental health have generated as much controversy over the last decade as the debate about the safety of antidepressant medication given to kids. In 2004, the FDA issued a “black box” warning claiming that antidepressant use in children and teenagers is associated with increases in suicidal thinking and behavior, which was expanded in 2007 to include adults between the ages of 18 and 24. In my opinion, the larger controversy about antidepressant use in children and teens is not “are they safe?” but “do they work?” and if they work, what do they work for? Some of those questions were addressed here.
One of the greatest ongoing controversies in the fields of child psychiatry and pediatrics is the question of how safe SSRIs are in children, teens and young adults. The safety issue of greatest concern involves reported risks of SSRIs increasing suicidal thoughts during the first 30-60 days of treatment in persons under the age of 25.